More on: APHA APHA Summer may be here, but the sun is not shining on marijuana shareholders. After a series of quarterly reports that missed analyst expectations, the sector as a whole began tumbling, with Horizons Medical Marijuana Life Science ETF sliding 29% since March. While the marijuana sector is growing faster than ever, expenses are beginning to spiral out of control, with no clear path to profitability. Granted, it’s normal for young companies to post losses, but the fact that marijuana losses are growing ever larger as a percentage of revenue is not a good sign. On the surface, Aphria (TSX:APHA)(NYSE:APHA) looks like yet another weed producer that can’t get its spending under control. Its most recent quarter saw a huge jump in operating expenses resulting in a net loss that was approximately seven times greater than revenue. Is Aphria (USA) Stock an Undervalued Bargain?
thumbnail courtesy of www.fool.ca